Trials / Sponsors / Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc.
Industry · 8 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias Immune Thrombocytopenia, Idiopathic Thrombocytopenic Purpura, Warm Autoimmune Hemolytic Anemia | Phase 1 / Phase 2 | 2023-07-03 |
| Active Not Recruiting | An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases Lupus Nephritis, Immunoglobulin A Nephropathy, Membranous Nephropathy | Phase 1 / Phase 2 | 2023-03-15 |
| Completed | A Study of ALPN-303 in Adult Healthy Volunteers Healthy Volunteers | Phase 1 | 2021-11-15 |
| Terminated | ALPN-202 With PD-1 Inhibition in Advanced Malignancies Advanced Solid Tumor, Lymphoma | Phase 1 | 2021-06-22 |
| Terminated | An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies Advanced Solid Tumor, Lymphoma | Phase 1 | 2020-06-02 |
| Terminated | ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHD Graft Vs Host Disease | Phase 1 | 2020-05-11 |
| Completed | Cell Surface Marker Expression in Autoimmune Diseases Systemic Lupus Erythematosus, Sjogren's Syndrome, Multiple Sclerosis | — | 2019-06-12 |
| Completed | Adult Healthy Volunteers Study to Evaluate ALPN-101 Safety Healthy Volunteers | Phase 1 | 2019-01-29 |